NFKB1 and renal fibrosis: Treatment with 5-MTP alleviated renal fibrosis, suppressed IκB/NF-κB signaling pathway, and improved Keap1/Nrf2 signaling pathway in mice with UUO or ischemia/reperfusion injury and in human kidney cells 33.